All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Enrollment complete in first-in-human trial evaluating treatment for patients with Usher syndrome ➤ First patients randomized in drug-eluting IOL trial ➤ Preliminary data from Phase 2 gene modifier study for geographic atrophy ➤ ASCRS news and events
➤ FDA accepts BLA for thyroid eye treatment ➤ Breakthrough Therapy Designation granted to investigational neuroprotective for optic neuropathies ➤ FDA issues complete response letter for wet AMD BLA resubmission ➤ Biosimilar approved for retinal therapies ➤ FDA approves IND for corneal genome editing program ➤ Study: ‘largest prospective trial ever’ on postcataract endophthalmitis prophylaxis ➤ Complimentary access to video journal ➤ Company news ➤ ASCRS news and events
When considering cataract surgery, one of the most basic steps is choosing the incision to be used. EyeWorld spoke to several experts about the impact of these incisions, sizing considerations, and important techniques and principles to ensure a successful surgery.
While not a common approach or its primary indication, the ICL (STAAR Surgical) can be used as a supplementary/piggyback IOL in some patients. Three physicians discussed how this off-label approach to using the ICL is opening doors to treat certain patients.
It was a successful year for the Journal of Cataract & Refractive Surgery (JCRS), the official journal of ASCRS and ESCRS, and JCRS Online Case Reports (JCRO), an online-only companion journal to JCRS. To celebrate this success, EyeWorld is featuring some of the most-viewed papers.
Patients with disabilities can experience unique challenges when in need of cataract surgery, but some ophthalmologists say the challenge for these patients begins before they ever sit in an exam chair. This vulnerable patient population can face ethical, logistical, and systemic barriers to care.
➤ New trifocal receives FDA approval ➤ Robotic system completes its first cataract surgery ➤ Interim results from first-in-human bimatoprost-IOL system ➤ Reproducible regenerative effects observed in preclinical glaucoma model ➤ Phase 3 program begins for intravitreal insert treating wet AMD, DME ➤ ASCRS news and events
EyeWorld reports on the BRiCS Summit, which took place October 3–5 in Chicago, Illinois. What the course really boils down to is increasing confidence in the premium IOL practice through education, resources, and networking connections, according to Vance Thompson, MD, chair, and William Wiley, MD, co-director.
With an increase in dry eye education and treatment options, questions can arise: Who really needs surface optimization vs. who is ready to schedule surgery now? What’s reasonable in terms of treatment? When is a patient who needed ocular surface optimization ready for surgery? Two experts shared their experiences.